Nasacort Allergy 24HR Nasal Spray is now available over-the-counter (OTC) in the United States, according to a news announcement by Sanofi and its US consumer healthcare division Chattem.
The medication is designed to relieve the full range of seasonal and year-round nasal allergy symptoms, including nasal congestion, in adults and children 2 years of age and older. Nasacort Allergy 24HR is the first and only medicine in its class to be available at full prescription strength without the need for a prescription, according to Sanofi/Chattem.
Nasacort is part of the most effective class of medicine for the treatment of hay fever and other upper respiratory allergies, and the only medicine in this class available OTC. It works differently than other over-the-counter treatments to relieve the full range of nasal allergy symptoms, including nasal congestion, by stopping more of the chemical responses that cause those symptoms.
“The launch of Nasacort Allergy 24HR represents our long-standing commitment to helping individuals living with allergies,” said Anne Whitaker, President North America Pharmaceuticals, Sanofi US. “This milestone builds on our heritage in the allergy category and our expertise in prescription to over-the-counter switches as we continue to expand our global consumer healthcare organization.”
Nasacort received approval from the US Food and Drug Administration (FDA) to switch from prescription to OTC on October 11, 2013, and is now available on retail shelves nationwide.
